Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kovar

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Urology|September 4, 1999
In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancerT P Beck, E J Kirsh, S J Chmura, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|March 1, 1993
Effect of a walking program on gait characteristics in patients with osteoarthritisM G Peterson, P A Kovar-Toledano, J C Otis, et al.
Psychopharmacology|April 2, 1999
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled studyE Gouzoulis-Mayfrank, B Thelen, E Habermeyer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDGE Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potentialZ Dubauskas, T P Beck, S J Chmura, et al.
Frontiers in Pharmacology|February 11, 2026
Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in GermanyR Schultz-Heienbrok, S Baumann, R Böhm, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Urology|September 4, 1999
In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancerT P Beck, E J Kirsh, S J Chmura, et al.
Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|March 1, 1993
Effect of a walking program on gait characteristics in patients with osteoarthritisM G Peterson, P A Kovar-Toledano, J C Otis, et al.
Psychopharmacology|April 2, 1999
Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled studyE Gouzoulis-Mayfrank, B Thelen, E Habermeyer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 18, 1999
Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDGE Gouzoulis-Mayfrank, M Schreckenberger, O Sabri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potentialZ Dubauskas, T P Beck, S J Chmura, et al.
Frontiers in Pharmacology|February 11, 2026
Designing integrated early-phase protocols to reduce substantial modifications, including considerations for patient cohorts - a multi-stakeholder consensus view for a practical approach in GermanyR Schultz-Heienbrok, S Baumann, R Böhm, et al.
Pageof 7